Nalaganje...

Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: Implications for Pierson syndrome

Pierson syndrome is a recently defined disease usually lethal within the first postnatal months and caused by mutations in the gene encoding laminin β2 (LAMB2). The hallmarks of Pierson syndrome are congenital nephrotic syndrome accompanied by ocular abnormalities, including microcoria (small pupils...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Miner, Jeffrey H., Go, Gloriosa, Cunningham, Jeanette, Patton, Bruce L., Jarad, George
Format: Artigo
Jezik:English
Izdano: 2006
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1363729/
https://ncbi.nlm.nih.gov/pubmed/16452099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1242/dev.02270
Oznake: Označite
Brez oznak, prvi označite!
id pubmed-1363729
record_format dspace
spelling pubmed-13637292006-09-01 Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: Implications for Pierson syndrome Miner, Jeffrey H. Go, Gloriosa Cunningham, Jeanette Patton, Bruce L. Jarad, George Development Article Pierson syndrome is a recently defined disease usually lethal within the first postnatal months and caused by mutations in the gene encoding laminin β2 (LAMB2). The hallmarks of Pierson syndrome are congenital nephrotic syndrome accompanied by ocular abnormalities, including microcoria (small pupils), with muscular and neurological developmental defects also present. Lamb2−/− mice are a model for Pierson syndrome; they exhibit defects in the kidney glomerular barrier, in the development and organization of the neuromuscular junction, and in the retina. Lamb2−/− mice fail to thrive and die very small at 3 weeks of age, but to what extent the kidney and neuromuscular defects each contribute to this severe phenotype has been obscure, though highly relevant to understanding Pierson syndrome. To investigate this, we generated transgenic mouse lines expressing rat laminin β2 either in muscle or in glomerular epithelial cells (podocytes) and crossed them onto the Lamb2−/− background. Rat β2 was confined in skeletal muscle to synapses and myotendinous junctions, and in kidney to the glomerular basement membrane. In transgenic Lamb2−/− mice, β2 deposition only in glomeruli prevented proteinuria but did not ameliorate the severe phenotype. In contrast, β2 expression only in muscle restored synaptic architecture and led to greatly improved health, but the mice died from kidney disease at 1 month. Rescue of both glomeruli and synapses was associated with normal weight gain, fertility, and lifespan. We conclude that muscle defects in Lamb2−/− mice are responsible for the severe failure to thrive phenotype, and that renal replacement therapy alone will be an inadequate treatment for Pierson syndrome. 2006-02-01 2006-03 /pmc/articles/PMC1363729/ /pubmed/16452099 http://dx.doi.org/10.1242/dev.02270 Text en
institution US National Library of Medicine
collection PubMed Central
language English
format Article
topic Article
spellingShingle Article
Miner, Jeffrey H.
Go, Gloriosa
Cunningham, Jeanette
Patton, Bruce L.
Jarad, George
Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: Implications for Pierson syndrome
description Pierson syndrome is a recently defined disease usually lethal within the first postnatal months and caused by mutations in the gene encoding laminin β2 (LAMB2). The hallmarks of Pierson syndrome are congenital nephrotic syndrome accompanied by ocular abnormalities, including microcoria (small pupils), with muscular and neurological developmental defects also present. Lamb2−/− mice are a model for Pierson syndrome; they exhibit defects in the kidney glomerular barrier, in the development and organization of the neuromuscular junction, and in the retina. Lamb2−/− mice fail to thrive and die very small at 3 weeks of age, but to what extent the kidney and neuromuscular defects each contribute to this severe phenotype has been obscure, though highly relevant to understanding Pierson syndrome. To investigate this, we generated transgenic mouse lines expressing rat laminin β2 either in muscle or in glomerular epithelial cells (podocytes) and crossed them onto the Lamb2−/− background. Rat β2 was confined in skeletal muscle to synapses and myotendinous junctions, and in kidney to the glomerular basement membrane. In transgenic Lamb2−/− mice, β2 deposition only in glomeruli prevented proteinuria but did not ameliorate the severe phenotype. In contrast, β2 expression only in muscle restored synaptic architecture and led to greatly improved health, but the mice died from kidney disease at 1 month. Rescue of both glomeruli and synapses was associated with normal weight gain, fertility, and lifespan. We conclude that muscle defects in Lamb2−/− mice are responsible for the severe failure to thrive phenotype, and that renal replacement therapy alone will be an inadequate treatment for Pierson syndrome.
author Miner, Jeffrey H.
Go, Gloriosa
Cunningham, Jeanette
Patton, Bruce L.
Jarad, George
author_facet Miner, Jeffrey H.
Go, Gloriosa
Cunningham, Jeanette
Patton, Bruce L.
Jarad, George
author_sort Miner, Jeffrey H.
title Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: Implications for Pierson syndrome
title_short Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: Implications for Pierson syndrome
title_full Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: Implications for Pierson syndrome
title_fullStr Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: Implications for Pierson syndrome
title_full_unstemmed Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: Implications for Pierson syndrome
title_sort transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: implications for pierson syndrome
publishDate 2006
url https://ncbi.nlm.nih.gov/pmc/articles/PMC1363729/
https://ncbi.nlm.nih.gov/pubmed/16452099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1242/dev.02270
_version_ 1760299738167508992